US Producer Prices Rise 6.5% in October, Keeping Fed Policy in Focus
October producer prices were slightly softer than forecast, but elevated inflation keeps Federal Reserve policy, bond yields and rate-sensitive equities in focus.
UniFirst-Cintas Deal Spread Widens as FTC 'Last Rites' Report Raises Antitrust Risk
A reported FTC “last rites” meeting has widened the UniFirst-Cintas deal spread, signaling higher ma…
FTC Merger Challenge Puts $3.5 Billion Covetrus-MWI Deal Spread in Focus
A reported FTC lawsuit to block the $3.5 billion Covetrus-MWI deal puts antitrust risk and merger-ar…
Cisco Raises AI Infrastructure Stakes After Earnings Beat and Revenue-Doubling Forecast
Cisco beat quarterly earnings expectations and forecast that AI infrastructure revenue will double t…
Cerebras Surges 13% After Revenue Beat and Microsoft Cloud Partnership
Cerebras shares rose 13% after a quarterly revenue beat and a new Microsoft partnership expanded its…
Nvidia Shares Face New Pressure as Lutnick Agrees to Testify on China Chip Sales
Nvidia’s 5% drop puts political scrutiny, China sales uncertainty and leadership concerns at the cen…
IBM’s AuthMind Acquisition Extends Its Push Into Cybersecurity
IBM’s AuthMind acquisition reinforces its cybersecurity and hybrid-cloud strategy, while leaving inv…
Hancock Whitney-Trustmark Deal Signals Fresh Wave of Regional Bank Consolidation
Hancock Whitney’s approximately $3.2 billion all-stock acquisition of Trustmark highlights renewed c…
Investcorp Credit Management BDC Surges More Than 50% on BCP Investment Merger Deal
Investcorp Credit Management BDC shares jumped more than 50% after news of a merger deal with BCP In…
Costco Announces Special Dividend as Shareholders Watch Holiday Payout
Costco’s special dividend highlights its capital-return strategy, while shareholders focus on the re…
Installed Building Products’ $698 Million Old Dominion Deal Puts Sector Consolidation in Focus
Installed Building Products’ $698 million acquisition of Old Dominion Group highlights consolidation…
Half-Point Fed Hike Risk Raises Stakes for U.S. Stocks, Bonds and Housing
A possible half-point Fed hike is jolting expectations across stocks, bonds, mortgages, corporate cr…
JetBlue CEO Bets on Premium Strategy Despite Creditor Concerns
JetBlue is betting that premium offerings and new first-class seats can support its turnaround as cr…
Markets
- Sabre Shares Jump on Report of Potential Travelport Combination
- Altius Minerals’ $122 Million TNR Gold Deal Signals Fresh Canadian Mining Consolidation
- GFL Environmental Drops After Strategic Review Ends Without a Sale
- GFL Ends Strategic Review After Rejecting $52-a-Share Private Equity Offer
Economy
- Hot Inflation Data Sends Mortgage Rates Higher as Wall Street Rate-Cut Hopes Fade
- Retail Sales Growth Slows to Nearly One-Year Low as Consumer Strain Builds
- Reuters Poll Points to Another Fed Rate Hike as Inflation Risks Persist
- US Payrolls Beat and Canadian Jobs Miss Push USD/CAD Higher
Analysis
- Airbnb Shares Rise 5.64% as Golden Cross Signals Renewed Technical Momentum
- Donchian Channel Breakout: 10-Year ETF Backtest
- MACD vs Moving Average Crossover: 9-Year SPY, QQQ Test
- ADX Trend Strength: What 10 Years of ETF Data Show
Earnings
- Boeing’s 5% Workforce Cut Signals Slower Commercial-Airplane Recovery
- ConocoPhillips Raises Dividend After Earnings Beat as Oil Prices Support Results
- Utz Brands Reports Third-Quarter Results as Snack Investors Track Consumer Pressures
- Marathon Petroleum’s Earnings Beat Puts Refining Consolidation in the Spotlight
Technology
- Chip Stocks Rally Despite Nvidia Scandal as Traders Test a Potential Market Bottom
- Meta Executive’s Move to Fireworks Highlights Intensifying AI Talent War
- Palo Alto Networks’ Reported $500 Million Clutch Talks Put AI Security M&A in Focus
- CrowdStrike’s $495 Million AI Security Bet Puts Autonomous Defense in Focus
IPO
- Anthropic IPO Filing Ignites Tech Rally While Founder Control Tests Investors
- TriGemX Bio’s $600 Million SPAC Merger Creates a New Nasdaq Biotech Watchlist Name
- XTEND AI Robotics: Analyzing the Market Implications of Its NYSE Debut
- Werewolf Therapeutics and Ambros' Merger: A New Era in Biotech